Pinealon side effects and risks
A peptide with unproven brain benefits and no established injection dose.
Also called: EDR, Glu-Asp-Arg, glutamyl-aspartyl-arginine.
Khavinson bioregulator peptides · Synthetic tripeptide studied for nerve-cell protection.
Reported side effects
- Sleep disruption and head pressure: Personal reports; no population rate or confirmed causality., moderate. Stop and review persistent symptoms; seek urgent care for severe new symptoms. (source)
- Injection infection or serious allergy: No Pinealon specific incidence is available., serious (source)
Stop and get help if
- Trouble breathing, throat or tongue swelling, or collapse: Stop use and call emergency services now.
- Fever with spreading injection-site redness, confusion or fast breathing: Seek urgent emergency care for possible severe infection.
Who should avoid it
- pregnant: No human pregnancy safety data. Precautionary exclusion.
- breastfeeding: Milk transfer and infant effects are unknown. Precautionary exclusion.
- tryingToConceive: Fertility effects and a safe washout interval are unknown. Precautionary exclusion.
- under18: Child safety is unestablished. Small reports do not establish a safe pediatric dose.
- kidneyDisease: Human clearance and dose adjustment in kidney disease are unknown.
- liverDisease: Human clearance and dose adjustment in liver disease are unknown.
- psychiatricCondition: Sleep disruption or agitation may worsen existing symptoms. Human psychiatric safety is untested.
- seizureDisorder: Seizure safety and interactions with seizure medicines have not been established.
- other: Avoid re-exposure after a serious allergic reaction.
- testedAthlete: Treat as prohibited under WADA S0. This applies the class rule; neither peptide is named.
- bleedingDisorder: Needle injections can cause bleeding or a hematoma. This is a procedure risk.
- activeCancer: Cell-growth effects have been reported. Human cancer safety is unknown; review with the oncology team.
Interactions
- Anticoagulants during intramuscular injections: IM injections can cause bruising or hematoma. A peptide-specific drug interaction has not been studied.
- Insulin and sulfonylureas: No human interaction study or dose-adjustment rule was found. Do not infer a need to change diabetes medicines.
- Serotonergic medicines: Brain-cell studies show serotonin changes. A human interaction or serotonin-syndrome risk has not been demonstrated.
- Epitalon or other experimental brain peptides: Combination safety is unstudied. A Pinealon/Epitalon user reported marked sleep disruption.
Product quality risks
- Health Canada seized unauthorized Pinealon injections. No independent market survey of Pinealon vial content or contamination was found.
- Unapproved injections can contain the wrong drug, the wrong amount, microbes or bacterial toxins called endotoxin.
- A research-only label, clear solution or high purity percentage does not establish injection quality.
Related to Pinealon
- Epitalon: A peptide with telomerase effects in cells, but no proof that people live longer.
- Thymalin: A calf thymus extract studied for immune problems, with uncertain safety and product identity.
- Thymogen: A Russian peptide used for immune problems, with negative cancer trials.
- Vesugen: An experimental blood-vessel peptide with unclear benefits and poorly defined safety.
- Cortagen: A four-amino-acid brain peptide backed mainly by animal work and unverified patent claims.
- DSIP: An experimental sleep peptide with small, mixed human studies and no FDA-approved dose.
Sources
- 503B Bulk Drug Substances List, FDA · FDA · 2026
- Bulk Drug Substances Nominated for Use in Compounding Under Section 503A of the Federal Food, Drug, and Cosmetic Act, FDA · FDA · 2026
- Bulk Drug Substances Used in Compounding Under Section 503A of the FD&C Act, FDA · FDA · 2026
- July 23-24, 2026, Meeting of the Pharmacy Compounding Advisory Committee – FDA Briefing Document for Epitalon-Related Bulk Drug Substances (Epitalon (free base) and Epitalon acetate), FDA · 2026
- Medicines, European Medicines Agency · European Medicines Agency · 2026
- MHRA Products | Home, MHRA · MHRA · 2026
- Peptide products, Therapeutic Goods Administration · TGA · 2026
- Risks of buying peptide products online, Therapeutic Goods Administration · 2026
- Sepsis, NHS · 2026
- The 2026 Prohibited List, World Anti-Doping Agency · WADA · 2026
- Therapeutic Goods (Poisons Standard—October 2026) Instrument 2026, Australian Government · Australian Government · 2026
- Think twice before injecting peptides bought online: unauthorized products can seriously harm you, Health Canada · Health Canada · 2026
- Anaphylaxis, NHS · NHS · 2023
- Using intramuscular injections in people on oral anticoagulants, NHS Specialist Pharmacy Service · NHS Specialist Pharmacy Service · 2023
- Preventing Unsafe Injection Practices, Centers for Disease Control and Prevention
Sources checked: 2026-10-18.
Information only, not medical advice. Peptifacts does not sell anything and does not link to sellers.